Skip to main content
E.S.F.H logo

E.S.F.H — Investor Relations & Filings

Ticker · 2884 ISIN · TW0002884004 LEI · 549300X6CNQE512OPC90 TW Financial and insurance activities
Open in API
Filings indexed 3,410 across all filing types
Latest filing 2022-04-08 Regulatory Filings
Country TW Taiwan
Listing TW 2884

About E.S.F.H

https://www.esunfhc.com

E.SUN Financial Holding Co., Ltd. is a comprehensive financial services provider that operates primarily through its flagship subsidiary, E.SUN Bank, alongside E.SUN Securities. The company offers a diverse range of services including corporate banking, retail banking, wealth management, and securities brokerage. Its core business activities encompass enterprise financing, foreign exchange, and financial market operations. E.SUN is recognized for its leadership in sustainable finance, being a pioneer in issuing sustainability development bonds focused on renewable energy, biodiversity, and environmental conservation. The firm is distinguished by its high standards of corporate governance and environmental, social, and governance (ESG) performance, consistently earning top-tier international ratings and inclusion in global sustainability indices. With an expanding regional presence, the company focuses on delivering professional financial solutions and long-term value.

Recent filings

Filing Released Lang Actions
111年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from 玉山金 (E.SUN Financial Holding Co.) regarding the status of funds lending balances and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or meeting. The content is a regulatory disclosure of financial guarantees and lending balances, typical of a regulatory filing or compliance announcement. Given the short length (602 characters) and the nature of the data, it does not qualify as a full financial report or earnings release. It fits best under Regulatory Filings (RNS) as a general compliance disclosure.
2022-04-08 Chinese
111年3月營業收入
Regulatory Filings Classification · 95% confidence The document is very short (449 characters) and consists mainly of a summary table listing company codes and names related to a financial holding company and its subsidiaries. It includes a note about monthly revenue reporting under ROC or IFRS standards. There is no detailed financial data, no report content, no management discussion, no voting results, no legal or regulatory announcements, and no indication of a specific report being attached or published. The content is informational and regulatory in nature but does not fit into any specific detailed report category. Given the short length and nature of the content, it best fits the fallback category for general regulatory announcements or miscellaneous filings that do not fit other categories, which is Regulatory Filings (RNS).
2022-04-08 Chinese
公告本公司暨子公司111年03月自結盈餘
Regulatory Filings Classification · 95% confidence The document is a short announcement from a listed company (玉山金控) reporting its unaudited monthly earnings for March 111 (Taiwan calendar year). It provides summarized financial figures such as pre-tax and after-tax earnings and earnings per share, explicitly stating these are self-reported and unaudited. The document length is only 971 characters, which is quite brief and does not contain detailed financial statements or comprehensive analysis. It is not a full quarterly or annual report, nor an earnings release with key highlights and management commentary. Instead, it is a regulatory announcement of monthly earnings data, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-04-08 Chinese
本公司代子公司玉山創投公告出售醣基生醫股份有限公司股票
Capital/Financing Update Classification · 95% confidence The document is a short announcement from a listed company (2884 玉山金) disclosing the sale of shares of another company (醣基生醫股份有限公司). It includes details such as transaction dates, quantities, prices, profits, and related party information. The content focuses on a specific transaction involving securities disposal and does not contain financial statements, management discussion, or detailed financial results. It is a regulatory disclosure about a capital transaction rather than a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2022-03-31 Chinese
110年第4季海外子公司投資
Regulatory Filings Classification · 90% confidence The document is a financial disclosure related to investment holdings and equity method accounting for overseas subsidiaries, including investment amounts and recognized gains or losses. It is relatively short (741 characters) and appears to be a regulatory disclosure of investment details rather than a full financial report. There is no indication that this is a full annual or interim report, audit report, or earnings release. It does not contain management discussion or call transcript content. The document is a regulatory filing providing specific financial data about investments, consistent with a general regulatory announcement rather than a comprehensive report. Therefore, the best classification is Regulatory Filings (RNS).
2022-03-23 Chinese
110年第4季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investments made by a Taiwanese listed company (玉山金) into mainland China entities, including investment amounts, methods, and related notes. It includes financial figures but is primarily an investment disclosure rather than a full financial report. The document length is 2153 characters, which is relatively short and does not contain comprehensive financial statements or management discussion. It does not appear to be an announcement of a report but rather a regulatory disclosure of investment details. This type of document fits best under Regulatory Filings (RNS), as it is a compliance disclosure related to cross-border investments without being a full annual or interim report, audit report, or other specific filing types.
2022-03-23 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.